FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/092643 [Registered on: 08/08/2025] Trial Registered Prospectively
Last Modified On: 07/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Study to assess allergic rhinitis using homoeopathic medicines 
Scientific Title of Study   Effectiveness of Homoeopathic Medicines in LM Potency for Managing Perennial Allergic Rhinitis: A Prospective Study Using RCAT Score 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Roy Thomas 
Designation  Junior Resident 
Affiliation  Sarada Krishna Homoeopathic Medical College & Hospital 
Address  Dept. of Organon of Medicine SKHMC
Kulasekharam Kanniyakumari District
Kanniyakumari
TAMIL NADU
629161
India 
Phone  09746571384  
Fax    
Email  roythomascall@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Roy Thomas 
Designation  Junior Resident 
Affiliation  Sarada Krishna Homoeopathic Medical College & Hospital 
Address  Dept. of Organon of Medicine SKHMC
Kulasekharam Kanniyakumari District
Kanniyakumari
TAMIL NADU
629161
India 
Phone  09746571384  
Fax    
Email  roythomascall@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Roy Thomas 
Designation  Junior Resident 
Affiliation  Sarada Krishna Homoeopathic Medical College & Hospital 
Address  Dept. of Organon of Medicine SKHMC
Kulasekharam Kanniyakumari District
Kanniyakumari
TAMIL NADU
629161
India 
Phone  09746571384  
Fax    
Email  roythomascall@gmail.com  
 
Source of Monetary or Material Support  
INSTITUTION - Sarada krishna homoeopathic medical college, Kulasekharam, Kanniyakumari district, Tamilnadu,India 629161 
 
Primary Sponsor  
Name  Post graduate research funded by college. To  
Address  Sarada Krishna Homoeopathic Medical College and Hospital, Kanniyakumari district, Tamilnadu 629161 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr MANOJ NARAYAN V  Sarada Krishna Homoeopathic Medical College  Room No 403 III floor Department of Organon,Opd,Ipd,Rural Health Centres, Sarada Krishna Homoeopathic Medical College, Kulasekharam, Kanniyakumari, TamilNadu,629161. Kanniyakumari TAMIL NADU
Kanniyakumari
TAMIL NADU 
9995114518

manojnarayanv@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHHICAL COMMITTEE SARADA KRISHNA HOMOEOPATHIC MEDICALCOLLEGE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J308||Other allergic rhinitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Homoeopathic Medicines in LM Potency  Standardized homoeopathic medicines in LM potency through oral route one dose for once in 2 weeks and is followed for a period of 3 months . The medicine is selected based on common clinical indications for perennial allergic rhinitis. Medicines administered in water doses with standardized dispensing protocol. Outcome assessed using RCAT Score. 
Comparator Agent  Not applicable  Not applicable 
 
Inclusion Criteria  
Age From  6.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Acute upper respiratory tract infections.
2. Presence of bronchial asthma or other chronic respiratory illness.
3. Use of anti-allergic or steroidal medications during the study period.
4. Known hypersensitivity to any of the ingredients in the medicine used.
5. Pregnant or lactating women.
6. Patients with serious systemic illness. 
 
ExclusionCriteria 
Details  1. Patients suffering from acute upper respiratory tract infections.
2. Patients having bronchial asthma and other chronic respiratory conditions.
3. Patients under anti-allergic treatment.
4. Pregnant and lactating women.
5. Patients with serious systemic illness. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in RCAT (Rhinitis Control Assessment Test) score.  Baseline, at 2-week intervals during treatment.  
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in use of conventional anti-allergic medications. The medicine will be administered orally, one dose, once in 2 weeks for a period of 3 months
 
The assessment will be done at baseline & at 3 months 
Reduction in use of conventional anti-allergic medications.  Throughout the treatment period. 
 
Target Sample Size   Total Sample Size="34"
Sample Size from India="34" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   20/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a prospective, single-arm, observational study conducted at Sarada Krishna Homoeopathic Medical College and Hospital (SKHMC), Kulasekharam, to evaluate the effectiveness of individualized homoeopathic medicines in LM potency for managing perennial allergic rhinitis using the Rhinitis Control Assessment Test (RCAT) score. Thirty-four pre-diagnosed cases fulfilling the inclusion criteria will be selected purposively from the OPD, IPD, and rural health training centres. Follow-up will be done weekly or biweekly for one year. Outcomes include change in symptom control and reduction in the need for conventional anti-allergic medications. 
Close